NO963168D0 - Immunstimulatoriske monoklonale antistoffer - Google Patents

Immunstimulatoriske monoklonale antistoffer

Info

Publication number
NO963168D0
NO963168D0 NO963168A NO963168A NO963168D0 NO 963168 D0 NO963168 D0 NO 963168D0 NO 963168 A NO963168 A NO 963168A NO 963168 A NO963168 A NO 963168A NO 963168 D0 NO963168 D0 NO 963168D0
Authority
NO
Norway
Prior art keywords
monoclonal antibodies
immunostimulatory monoclonal
tumor
immunostimulatory
elicts
Prior art date
Application number
NO963168A
Other languages
English (en)
Other versions
NO963168L (no
NO317020B1 (no
Inventor
Britts Hardy
Avraham Novogrodsky
Original Assignee
Mor Research Applic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mor Research Applic Ltd filed Critical Mor Research Applic Ltd
Publication of NO963168D0 publication Critical patent/NO963168D0/no
Publication of NO963168L publication Critical patent/NO963168L/no
Publication of NO317020B1 publication Critical patent/NO317020B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)
NO19963168A 1994-01-31 1996-07-29 Immunstimulatoriske monoklonale antistoffer NO317020B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10850194A IL108501A (en) 1994-01-31 1994-01-31 Antibodies and pharmaceutical compositions containing them
PCT/US1995/001137 WO1995020605A1 (en) 1994-01-31 1995-01-30 Immuno-stimulatory monoclonal antibodies

Publications (3)

Publication Number Publication Date
NO963168D0 true NO963168D0 (no) 1996-07-29
NO963168L NO963168L (no) 1996-09-27
NO317020B1 NO317020B1 (no) 2004-07-26

Family

ID=11065761

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963168A NO317020B1 (no) 1994-01-31 1996-07-29 Immunstimulatoriske monoklonale antistoffer

Country Status (20)

Country Link
US (1) US5897862A (no)
EP (1) EP0742795B1 (no)
JP (1) JP3478398B2 (no)
CN (1) CN1052733C (no)
AT (1) ATE171461T1 (no)
AU (1) AU693526B2 (no)
CA (1) CA2182289C (no)
DE (1) DE69504955T2 (no)
DK (1) DK0742795T3 (no)
EE (1) EE03285B1 (no)
ES (1) ES2124533T3 (no)
FI (1) FI963004A (no)
IL (1) IL108501A (no)
LT (1) LT4225B (no)
LV (1) LV11624B (no)
MD (1) MD1374G2 (no)
MX (1) MX9603080A (no)
NO (1) NO317020B1 (no)
RU (1) RU2155190C2 (no)
WO (1) WO1995020605A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129299A0 (en) * 1999-03-31 2000-02-17 Mor Research Applic Ltd Monoclonal antibodies antigens and diagnosis of malignant diseases
IL145926A0 (en) 2001-10-15 2002-07-25 Mor Research Applic Ltd Peptide epitopes of mimotopes useful in immunomodulation
IL149820A0 (en) 2002-05-23 2002-11-10 Curetech Ltd Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
EP3287144A1 (en) 2002-07-03 2018-02-28 ONO Pharmaceutical Co., Ltd. Immunopotentiating compositions
DE10311248A1 (de) * 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
WO2006021955A2 (en) * 2004-08-23 2006-03-02 Mor Research Applications Ltd. Use of bat monoclonal antibody for immunotherapy
EP2418278A3 (en) 2005-05-09 2012-07-04 Ono Pharmaceutical Co., Ltd. Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
AU2006265108C1 (en) 2005-07-01 2013-01-17 E. R. Squibb & Sons, L.L.C. Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
EP3222634A1 (en) * 2007-06-18 2017-09-27 Merck Sharp & Dohme B.V. Antibodies to human programmed death receptor pd-1
PT2242773T (pt) * 2008-02-11 2017-09-15 Cure Tech Ltd Anticorpos monoclonais para o tratamento de tumores
MD3972C2 (ro) * 2009-03-11 2010-07-31 Ион МЕРЕУЦЭ Remediu şi metodă de tratament al stărilor precanceroase
EP2734551B1 (en) 2011-07-24 2018-01-10 Cure Tech Ltd. Variants of humanized immunomodulatory monoclonal antibodies
EP3049442A4 (en) 2013-09-26 2017-06-28 Costim Pharmaceuticals Inc. Methods for treating hematologic cancers
US9580504B1 (en) 2013-11-07 2017-02-28 Curetech Ltd. Pidilizumab monoclonal antibody therapy following stem cell transplantation
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
JOP20200096A1 (ar) 2014-01-31 2017-06-16 Children’S Medical Center Corp جزيئات جسم مضاد لـ tim-3 واستخداماتها
TWI693232B (zh) 2014-06-26 2020-05-11 美商宏觀基因股份有限公司 與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法
WO2016040880A1 (en) 2014-09-13 2016-03-17 Novartis Ag Combination therapies of alk inhibitors
TWI773646B (zh) 2015-06-08 2022-08-11 美商宏觀基因股份有限公司 結合lag-3的分子和其使用方法
JO3736B1 (ar) 2015-07-30 2021-01-31 Macrogenics Inc جزيئات رابطة لـ pd-1 وطرق استخدامها
CN107949573B (zh) 2015-09-01 2022-05-03 艾吉纳斯公司 抗-pd-1抗体及其使用方法
AR106184A1 (es) 2015-09-29 2017-12-20 Celgene Corp Proteínas de unión a pd-1 y sus métodos de uso
LT3370768T (lt) 2015-11-03 2022-05-25 Janssen Biotech, Inc. Antikūnai, specifiškai surišantys pd-1, ir jų panaudojimas
MX2018007089A (es) 2015-12-14 2019-01-30 Macrogenics Inc Moleculas biespecificas que tienen inmunorreactividad con pd-1 y ctla-4, y metodos de uso de las mismas.
WO2017220989A1 (en) 2016-06-20 2017-12-28 Kymab Limited Anti-pd-l1 and il-2 cytokines
EP3515943A4 (en) 2016-09-19 2020-05-06 Celgene Corporation METHODS OF TREATING VITILIGO WITH PD-1 BINDING PROTEINS
SG11201901950TA (en) 2016-09-19 2019-04-29 Celgene Corp Methods of treating immune disorders using pd-1 binding proteins
GB202107994D0 (en) 2021-06-04 2021-07-21 Kymab Ltd Treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182368A (en) * 1986-06-13 1993-01-26 Ledbetter Jeffrey A Ligands and methods for augmenting B-cell proliferation

Also Published As

Publication number Publication date
CA2182289A1 (en) 1995-08-03
CN1145077A (zh) 1997-03-12
NO963168L (no) 1996-09-27
IL108501A0 (en) 1994-05-30
LV11624A (en) 1996-12-20
DE69504955T2 (de) 1999-05-27
ATE171461T1 (de) 1998-10-15
NO317020B1 (no) 2004-07-26
IL108501A (en) 1998-10-30
JP3478398B2 (ja) 2003-12-15
DK0742795T3 (da) 1999-06-14
LT4225B (en) 1997-10-27
EP0742795B1 (en) 1998-09-23
FI963004A (fi) 1996-09-27
MD1374F2 (en) 1999-12-31
RU2155190C2 (ru) 2000-08-27
AU1868695A (en) 1995-08-15
AU693526B2 (en) 1998-07-02
MX9603080A (es) 1998-01-31
JPH09508390A (ja) 1997-08-26
FI963004A0 (fi) 1996-07-29
DE69504955D1 (de) 1998-10-29
US5897862A (en) 1999-04-27
ES2124533T3 (es) 1999-02-01
LT96115A (en) 1997-05-26
EP0742795A1 (en) 1996-11-20
EE03285B1 (et) 2000-08-15
LV11624B (en) 1997-06-20
MD1374G2 (ro) 2000-09-30
CA2182289C (en) 2003-10-21
WO1995020605A1 (en) 1995-08-03
CN1052733C (zh) 2000-05-24

Similar Documents

Publication Publication Date Title
NO963168D0 (no) Immunstimulatoriske monoklonale antistoffer
DE69221147T2 (de) Nicht glycosylierter Anti-CD3-IgG-Antikörper
KR970702882A (ko) 암치료 및 암탐지를 위한 종양세포 생성 단백질의 모노클로날 항체(monoclonal antibody to oncofetal protein for treating and detecting cancer)
DE69319662D1 (de) Monoklonale Antikörper gegen GP130-Protein
DK0724456T3 (da) CD40-Antistoffer
DE68914244T2 (de) Monoklonaler Antikörper.
FI973484A (fi) Menetelmä immuunivasteen stimuloimiseksi
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
DE3884646D1 (de) Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
DK49291A (da) Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer
NO890116D0 (no) Monoklonale antistoffer.
DE3687542T2 (de) Monoklonaler antikoerper gegen humanes protein c.
DK413389A (da) Monoklonale antistoffer
DE68916088D1 (de) Anti-CPBII-monoklonaler Antikörper.
NZ314010A (en) A method of targeting intracellular binding proteins using a lipidized antibody
NO903788D0 (no) Monoklonalt antistoff mot protein c.

Legal Events

Date Code Title Description
MK1K Patent expired